16th Nov 2026 10:58
(Alliance News) - Applied Nutrition PLC on Monday maintained guidance after a strong financial year during which earnings and sales surged in response to strong demand.
The Liverpool-based sports nutrition and wellness products company said pretax profit rose 44% to GBP41.0 million for the financial year that ended July 31 from GBP28.5 million the year prior, or by 39% to GBP42.0 million from GBP30.2 million on an adjusted basis.
Revenue increased 51% to GBP161.6 million from GBP107.1 million following a "successful year of product launches, continued partnerships, and increased market penetration."
Adjusted earnings before interest, tax, depreciation and amortisation grew 40% to GBP43.3 million from GBP30.9 million, in line with upgraded management guidance provided in August.
Free cash flow was GBP10.6 million, down from GBP16.5 million.
Basic earnings per share increased to 12.2 pence from 8.4p.
No dividend was declared, and Applied Nutrition said it does not anticipate declaring a further dividend before financial 2028, retaining cash for investment in capacity, efficiency and potential M&A opportunities.
"FY26 was another year of strong growth for Applied Nutrition. We expanded our product range, strengthened existing key customer relationships and made our products available across more countries, channels and retailers than ever before," said Chief Executive Officer Thomas Ryder.
"Consumer demand for health, wellness and performance nutrition continues to grow and the market is moving quickly."
Looking ahead, Ryder said Applied Nutrition expects adjusted Ebitda for financial 2027 to grow to GBP49 million and revenue to increase to GBP205 million. This would be up 13% and 27%, respectively.
"Positive momentum has continued into the first quarter of FY27, with the group continuing to gain market share across key channels and seeing further opportunity to build its position both in the UK and internationally," the CEO said.
For now, Applied Nutrition believes it is "prudent" to maintain current market expectations, Ryder said.
Although the recent trajectory of raw material prices for whey protein has been to decrease, Applied Nutrition expects the cost as a raw material to be higher on average for financial 2027 than it was in financial 2026, mitigated by an increase in prices charged.
Shares in Applied Nutrition were down 3.5% at 304.51p pence each in London on Monday morning. They have risen 79% in the last 12 months and have more than doubled from the initial public offer price of 140p back in October 2024.
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Applied Nutrition PLC